Birmingham Children's University

Birmingham B4 6NH

0 studies enrolling now · 1 studies all time

What they study most

X-linked Hypophosphatemia

Studies at this site

• Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH) — Completed